Voyager Therapeutics, Inc.VYGRNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P0
Near historical low
vs 3Y Ago
-10x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-765.23%
2024-119.65%
2023722.90%
202276.63%
202144.66%
2020-298.73%
2019406.33%
201874.10%
2017-44.41%
2016-202.86%